Using advanced imaging to better evaluate kidney cancer
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
This study is testing a new imaging method to help doctors tell the difference between harmless and serious kidney tumors, which could help patients avoid unnecessary surgeries and get better treatment options, especially for older folks or those who can’t have surgery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10911839 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging technique called Magnetic Resonance Fingerprinting (MRF) to improve the evaluation of renal cell carcinoma (RCC). The goal is to create a non-invasive method that can accurately differentiate between benign and aggressive kidney tumors, which is crucial for determining the best treatment approach. By using advanced imaging technology, the researchers aim to reduce unnecessary surgeries and biopsies for patients with incidental renal masses. This approach could lead to better management strategies, especially for elderly patients or those who are not suitable candidates for surgery.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients aged 65 and older who have been diagnosed with incidental renal masses.
Not a fit: Patients with aggressive forms of renal cell carcinoma that require immediate intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce unnecessary treatments and improve patient outcomes by allowing for more accurate diagnosis and management of kidney tumors.
How similar studies have performed: Previous studies have shown promise in using advanced imaging techniques for cancer diagnosis, indicating that this approach may lead to successful outcomes.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Chen, Yong — Case Western Reserve University
- Study coordinator: Chen, Yong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.